PPARα agonists based on stilbene and its bioisosteres: biological evaluation and docking studies

MedChemComm
2015.0

Abstract

A new series of gemfibrozil analogues conjugated with trans-stilbene were synthesized and evaluated with the aim of developing new PPARα agonists. The phenyls of stilbene were modified by introducing substituents in the ortho or para position and only the distal ring was substituted with naphthyl or heteroaromatic moieties, keeping the dimethylpentanoic skeleton of gemfibrozil unaltered. Two compounds, 5a and 5d, exhibited good activation of PPARα and were also screened for their activity on PPARα-regulated gene CPT1A. Structure-based studies carried out on the active ligands highlighted the dominant role of ligand solvation energy and hydrophobic effect in determining the PPARα activation.

Knowledge Graph

Similar Paper

PPARα agonists based on stilbene and its bioisosteres: biological evaluation and docking studies
MedChemComm 2015.0
Structural development studies of PPARs ligands based on tyrosine scaffold
European Journal of Medicinal Chemistry 2015.0
Synthesis and structure–activity relationships of fibrate-based analogues inside PPARs
Bioorganic & Medicinal Chemistry Letters 2012.0
Synthesis, Biological Evaluation, and Molecular Modeling Investigation of New Chiral Fibrates with PPARα and PPARγ Agonist Activity
Journal of Medicinal Chemistry 2005.0
Modulation of PPAR subtype selectivity. Part 2: Transforming PPARα/γ dual agonist into α selective PPAR agonist through bioisosteric modification
Bioorganic & Medicinal Chemistry Letters 2011.0
A novel structural class of coumarin-chalcone fibrates as PPARα/γ agonists with potent antioxidant activities: Design, synthesis, biological evaluation and molecular docking studies
European Journal of Medicinal Chemistry 2017.0
Design, Synthesis, and Structural Analysis of Phenylpropanoic Acid-Type PPARγ-Selective Agonists: Discovery of Reversed Stereochemistry−Activity Relationship
Journal of Medicinal Chemistry 2011.0
Synthesis, biological evaluation, and molecular modeling investigation of chiral 2-(4-chloro-phenoxy)-3-phenyl-propanoic acid derivatives with PPARα and PPARγ agonist activity
Bioorganic & Medicinal Chemistry 2008.0
Design and Synthesis of α-Aryloxyphenylacetic Acid Derivatives:  A Novel Class of PPARα/γ Dual Agonists with Potent Antihyperglycemic and Lipid Modulating Activity
Journal of Medicinal Chemistry 2005.0
Synthesis and evaluation of a series of benzopyran derivatives as PPAR α/γ agonists
European Journal of Medicinal Chemistry 2008.0